# 2026-12653: DEA Issues Official Correction for Bromazolam Spelling Error

2026-12653, Schedules of Controlled Substances: Placement of Bromazolam in Schedule I; Correction, is a Federal Register rule from Justice Department, Drug Enforcement Administration published 2026-06-24, effective 2026-06-24; PRIA reads it as touching household money (as of 2026-07-01).

- Canonical: https://policyrisk.com/federal-register/2026-12653
- As of: 2026-07-01
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-12653
- Title: Schedules of Controlled Substances: Placement of Bromazolam in Schedule I; Correction
- Type: Rule
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 91 FR 37821
- Published: 2026-06-24
- Effective: 2026-06-24
- Comments close: not stated
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-07-01

## In one line

DEA Issues Official Correction for Bromazolam Spelling Error

## Summary

The DEA fixed a typo in the official chemical name of bromazolam, a drug they put in the strictest Schedule I category starting March 16, 2026. This correction makes the rules clear for everyone involved, especially law enforcement and drug handlers. No new fees or deadlines, just a clean-up to keep things accurate and official.

## Abstract

On March 16, 2026, the Drug Enforcement Administration published a temporary order placing 8-bromo-1-methyl-6-phenyl-4H- benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine (commonly known as bromazolam), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers are possible, in schedule I of the Controlled Substances Act. DEA published this temporary order that included an invalid chemical name for bromazolam. This document corrects that error, adding the valid chemical name for bromazolam.

## Effects PRIA read

- Bromazolam placed in Schedule I: cost, low. On March 16, 2026, the Drug Enforcement Administration placed bromazolam in Schedule I, the strictest category under the Controlled Substances Act. A correcting amendment effective June 24, 2026 fixes the official chemical name (8-bromo-1-methyl-6-phenyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazep…

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-20749](https://policyrisk.com/federal-register/2026-20749): Vladimir Romaniv, P.A.; Decision and Order, 2026-10-09
- [2026-20750](https://policyrisk.com/federal-register/2026-20750): L Krenk DBA Maui Clinic Pharmacy; Decision and Order, 2026-10-09

## Sources
- [2026-12653 on federalregister.gov](https://www.federalregister.gov/documents/2026/06/24/2026-12653/schedules-of-controlled-substances-placement-of-bromazolam-in-schedule-i-correction)
- [2026-12653 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-06-24/pdf/2026-12653.pdf)

## Related
- [Previous: 2026-12645, Rescission of Affirmative Outreach Requirements for Recipients of WIOA Title I…](https://policyrisk.com/federal-register/2026-12645)
- [Next: 2026-12654, Schedules of Controlled Substances: Temporary Placement of O-Desmethyltramadol…](https://policyrisk.com/federal-register/2026-12654)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-12653 (as of 2026-07-01).